10 Influenza


  1. Fine PEM, Mulholland K. 2013. Community immunity. In: Plotkin SA, Orenstein WA, Offit PA (eds). Vaccines (6th edition): Elsevier Saunders.
  2. Lowen AC, Mubareka S, Steel J, et al. 2007. Influenza virus transmission is dependent on relative humidity and temperature. PLOS Pathogens 3(10). DOI: 10.1371/journal.ppat.0030151
  3. Institute of Environmental Science and Research. 2013. 2013/44: 28 October–3 November 2013. Influenza Weekly Update. URL: (accessed 12 December 2013).
  4. The SHIVERS Project. 2013. 2013 influenza season, November 2013. Community and Hospital Surveillance: ILI, SARI, influenza and respiratory pathogens. URL: (accessed 18 January 2014).
  5. Public Health Commission. 1996. Influenza: The Public Health Commission’s advice to the Minister of Health 1995–1996. Wellington: Public Health Commission.
  6. Sprenger MJW, Mulder PGH, Beyer WEP, et al. 1993. Impact of influenza on mortality in relation to age and underlying disease, 1967–1989. International Journal of Epidemiology 22(2): 334–40.
  7. Ashley J, Smith T, Dunnell K. 1991. Deaths in Great Britain associated with the influenza epidemic of 1989/90. Population Trends 65:16–20.
  8. Institute of Environmental Science and Research. 2009. Seroprevalence of the 2009 Influenza A (H1N1) Pandemic in New Zealand. URL:
  9. Siston AM, Rasmussen SA, Honein MA, et al. 2010. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. Journal of the American Medical Association 303(15): 1517–25.
  10. Centers for Disease Control and Prevention. 2013. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices – United States, 2013–2014. Morbidity and Mortality Weekly Report: Recommendations and Reports 62(RR07). URL: (accessed 8 October 2013).
  11. Fiore AE, Bridges CB, Katz JM, et al. 2013. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit PA (eds). Vaccines (6th edition): Elsevier Saunders.
  12. Patel SM, Atmar RL, El Sahly HM, et al. 2012. Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes. Journal of Infectious Diseases 206(7): 1069–77.
  13. Roukens AHE, Gelinck LBS, Visser LG 2012. Intradermal vaccination to protect against yellow fever and influenza. Current Topics in Microbiology and Immunology 351: 159–79.
  14. Marra F, Young F, Richardson K, et al. 2012. A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events. Influenza and Other Respiratory Viruses 7(4). DOI: 10.1111/irv.12000 (accessed 15 December 2012).
  15. American Academy of Pediatrics. 2012. Influenza. In: Pickering LK, Baker CJ, Kimberlin DW, et al (eds). Red Book: 2012 report of the Committee on Infectious Diseases (29th edition). Elk Grove Village, IL: American Academy of Pediatrics.
  16. Esposito S, Tagliabue C, Tagliaferri L, et al. 2012. Preventing influenza in younger children. Clinical Microbiology and Infection 18(Suppl 5): 42–9.
  17. Eick AA, Uyeki TM, Klimov A, et al. 2011. Maternal influenza vaccination and effect on influenza virus infection in young infants. Archives of Pediatrics and Adolescent Medicine 165(2): 104–11.
  18. Govaert TME, Thijs C, Masurel N, et al. 1994. The efficacy of influenza vaccination in elderly individuals: a randomized double blind placebo controlled trial. Journal of the American Medical Association 272(21): 1661–5.
  19. Gross PA, Hermogenes AW, Sacks HS, et al 1995. The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature. The Annals of Internal Medicine 123(7): 518–27.
  20. Deguchi Y, Takasugi Y, Tatara K. 2000. Efficacy of influenza vaccine in the elderly in welfare nursing homes: Reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic. Journal of Medical Microbiology 49(6): 553–6.
  21. Gross PA, Quinnan GV, Rodstein M, et al. 1988. Association of influenza immunization with reduction in mortality in an elderly population: a prospective study. Archives of Internal Medicine 148(3): 562–5.
  22. Saah AJ, Neufeld R, Rodstein M, et al. 1986. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine 146(1): 2353–7.
  23. Jefferson T, Di Pietrantonj C, Al-Ansary LA, et al. 2010. Vaccines for preventing influenza in the elderly Cochrane Database of Systematic Reviews. Issue 2, Art. No. CD004876. DOI: 10.1002/14651858.CD004876.pub3 (accessed 13 November 2012).
  24. Beyer WEP, McElhaney J, Smith DJ, et al. 2013. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine 31(50). URL: (accessed 11 November 2013).
  25. Tamma PD, Ault KA, del Rio C, et al. 2009. Safety of influenza vaccination during pregnancy. American Journal of Obstetrics and Gynecology 201(6): 547–52.
  26. Poehling KA, Szilagyi PG, Staat MA, et al. 2011. Impact of maternal immunization on influenza hospitalizations in infants. American Journal of Obstetrics and Gynecology 204(6 Suppl 1): S141–8.
  27. Jefferson T, Rivetti A, Di Pietrantonj C, et al. 2012. Vaccines for preventing influenza in healthy children Cochrane Database of Systematic Reviews. Issue 8, Art. No. CD004879. DOI: 10.1002/14651858.CD004879.pub4 (accessed 13 November 2012).
  28. Osterholm MT, Kelley NS, Sommer A, et al. 2012. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. The Lancet Infectious Diseases 12(1): 36–44.
  29. Heinonen S, Silvennoinen H, Lehtinen P, et al. 2011. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. The Lancet Infectious Diseases 11(1): 23–9.
  30. Jefferson T, Di Pietrantonj C, Rivetti A, et al. 2010. Vaccines for preventing influenza in healthy adults Cochrane Database of Systematic Reviews. Issue 7, Art. No. CD001269. DOI: 10.1002/14651858.CD001269.pub4 (accessed 13 November 2012).
  31. Hak E, Buskens E, van Essen GA, et al. 2005. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Archives of Internal Medicine 165(3): 274–80.
  32. Looijmans-Van den Akker I, Verheij TJ, Buskens E, et al. 2006. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care 29(8): 1771–6.
  33. Poole PJ, Chacko E, Wood-Baker RW, et al. 2006. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. Issue 1, Art. No. CD002733. DOI: 10.1002/14651858.CD002733.pub2
  34. MacIntyre R, Heywood A, Kovoor P, et al. 2013. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart 99(24). DOI: 10.1136/heartjnl-2013-304320 (accessed 13 November 2013).
  35. Monto AS, Davenport FM, Napier JA, et al. 1970. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. Journal of Infectious Diseases 122(1–2): 16–25.
  36. Ghendon YZ, Kaira AN, Elshina GA. 2006. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiology and Infection 134(1): 71–8.
  37. Warburton MF, Jacobs D, Langsford W, et al. 1972. Herd immunity following subunit influenza vaccine administration. Medical Journal of Australia 2(2): 67–70.
  38. Oshitani H, Saito R, Seki N, et al. 2000. Influenza vaccination levels and influenza‐like illness in long‐term care facilities for elderly people in Niigata, Japan, during an influenza A (H3N2) epidemic. Infection Control and Hospital Epidemiology 21(11): 728–30.
  39. Hayward AC, Harling R, Wetten S, et al. 2006. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. British Medical Journal 33(7581): 1241.
  40. Foy HM, Cooney MK, McMahan R. 1973. Hong Kong influenza immunity three years after immunization. Journal of the American Medical Association 226(7): 758–61.
  41. Gaglani MJ, Piedra PA, Herschler GB, et al. 2004. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000–2001 influenza A(H1N1) and B epidemic in healthy children. Archives of Pediatric and Adolescent Medicine 158(1): 65–73.
  42. Ambrose CS, Yi T, Walker RE, et al. 2008. Duration of protection provided by live attenuated influenza vaccine in children. Pediatric Infectious Disease Journal 27(8): 744–8
  43. Ministry of Health. 2012. National Guidelines for Vaccine Storage and Distribution. URL:
  44. Zuckerman M, Cox R, Taylor J, et al. 1993. Rapid immune response to influenza vaccine. The Lancet 342(8879): 1113.
  45. Tse A, Tseng HF, Greene SK, et al. 2012. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010–2011. Vaccine 30(11): 2024–31.
  46. Van Buynder PG, Frosst G, Van Buynder JL, et al. 2012. Increased reactions to pediatric influenza vaccination following concomitant pneumococcal vaccination. Influenza and Other Respiratory Viruses 7(2). DOI: 10.1111/j.1750-2659.2012.00364.x (accessed 15 November 2012).
  47. Zaman K, Roy E, Arifeen SE, et al. 2008. Effectiveness of maternal influenza immunization in mothers and infants. New England Journal of Medicine 359(15): 1555–64.
  48. James JM, Zeiger RS, Lester MR, et al. 1998. Safe administration of influenza vaccine to patients with egg allergy. Journal of Pediatrics 133(5): 624–8.
  49. Erlewyn-Lajeunesse M, Brathwaite N, Lucas JSA, et al. 2009. Recommendations for the administration of influenza vaccine in children allergic to egg. British Medical Journal 339(1136): 3680.
  50. Australasian Society of Clinical Immunology and Allergy Inc. 2010. Influenza vaccination of the egg-allergic individual. ASCIA Guidelines for Medical Practitioners.
    URL: (accessed 8 October 2013).
  51. Govaert TME, Dinant GJ, Aretz K, et al. 1993. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. British Medical Journal 307(6910): 988–90.
  52. Margolis KL, Nichol KL, Poland GA, et al. 1990. Frequency of adverse reactions to influenza vaccine in the elderly. Journal of the American Medical Association 264(9): 1139–41.
  53. Nichol KL, Margolis KL, Lind A, et al. 1996. Side effects associated with influenza vaccination in healthy working adults: a randomized, placebo-controlled trial. Archives of Internal Medicine 156(14): 1546–50.
  54. Barry DW, Mayner RE, Hochstein HD, et al. 1975. Comparative trial of influenza vaccine. II: adverse reactions in children and adults. American Journal of Epidemiology 104(1): 47–59.
  55. Beyer WEP, Palache AM, Kerstens R, et al. 1996. Gender differences in local and systemic reactions of inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies. European Journal of Clinical Microbiology & Infectious Diseases 15(1): 65–70.
  56. National Institute for Health and Welfare. 2011. Association Between Pandemrix and Narcolepsy Confirmed Among Finnish Children and Adolescents. URL: (accessed 15 December 2012).
  57. World Health Organization. 2011. Statement on Narcolepsy and Vaccination. URL: (accessed 15 December 2012).
  58. Dauvilliers Y, Montplaisir J, Cochen V, et al. 2010. Post-H1N1 narcolepsy-cataplexy. Sleep 33(11): 1428–30.
  59. Han F, Lin L, Warby SC, et al. 2011. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Annals of Neurology 70(3): 410–7.
  60. World Health Organization. 2013. Global Advisory Committee on Vaccine Safety, 12–13 June 2013. Weekly Epidemiological Record 88(29). URL: (accessed 4 November 2013).
  61. Ministry of Health. 2010. New Zealand Influenza Pandemic Plan: A framework for action. URL: (accessed 29 August 2013).